Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOM230 LAR vs octreotide LAR in active acromegaly
CTR20131874Phase 3Completed
- Sponsor
- IgGenix
- Start
- Mar 2015
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of pasireotide LAR in acromegaly, sponsored by IgGenix. Started Mar 2015; status: completed.
02
Drugs
pasireotide LAR
03
Conditions
acromegaly
Beyond the preview
Go deeper on CTR20131874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131874.